Validating RNAseq-signatures of vorinostat (VOR) sensitivity and resistance in patients with newly diagnosed glioblastoma (GBM) treated with VOR, temozolomide and radiation therapy in Alliance N0874/ABTC-0902

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Jun 2016
EventASCO Annual Meeting - Chicago, IL
Duration: Jun 1 2016 → …

Conference

ConferenceASCO Annual Meeting
Period6/1/16 → …

Disciplines

  • Medicine and Health Sciences

Cite this